Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included House and Senate hearings on the cost of prescription drugs; a study finding patients with diabetes can be safely switched to cheaper insulin; and the first non-chemotherapy combination being approved for the treatment of chronic lymphocytic leukemia. Read more about the stories in this podcast: Senate Committee Discusses the Burden of High Drug Prices and Potential Solutions: https://www.ajmc.com/newsroom/senate-committee-discusses-the-burden-of-high-drug-prices-and-potential-solutions Medicare Patients With Type 2 Diabetes Safely Switched From Analog to Human Insulin, JAMA Study Finds: https://www.ajmc.com/newsroom/medicare-patients-with-type-2-diabetes-safely-switched-from-analog-to-human-insulin-ijamai-study-finds FDA Approves Ibrutinib Combination as Frontline Treatment for CLL: https://www.a